Protein-altering germline mutations implicate novel genes related to lung cancer development

Journal: Nature Communications

Published: 2020-05-11

DOI: 10.1038/s41467-020-15905-6

Affiliations: 84

Authors: 111

Go to article
Institutions Share
Department of Medicine, MSKCC, United States of America (USA) 0.06
NIH NCI Division of Cancer Epidemiology and Genetics (DCEG), United States of America (USA) 0.05
WHO International Agency for Research on Cancer (IARC), France 0.05
Institute for Clinical and Translational Research (ICTR), BCM, United States of America (USA) 0.04
Department of Biomedical Data Science (BMDS), Dartmouth College, United States of America (USA) 0.03
Harvard Department of Environmental Health (EH), United States of America (USA) 0.03
Lunenfeld-Tanenbaum Research Institute (LTRI), U of T, Canada 0.03
Faculty of Medicine, LU, Sweden 0.03
Institute of Translational Medicine (ITM), University of Liverpool, United Kingdom (UK) 0.03
Princess Margaret Cancer Centre, U of T, Canada 0.03
Department of Oncology and Metabolism, The University of Sheffield, United Kingdom (UK) 0.03
Marie-Josée and Henry R. Kravis Center for Molecular Oncology, MSKCC, United States of America (USA) 0.02
Copenhagen University Hospital (CUH), Denmark 0.02
Department of Genetic Epidemiology, University of Göttingen, Germany 0.02
Radboud Institute for Health Sciences (RIHS), RU, Netherlands 0.02
National Institute of Occupational Health (STAMI), Norway 0.02
Cancer Epidemiology Program, UH Mānoa, United States of America (USA) 0.02
Russian Oncological Scientific Center named after N.N.Blokhin, RAMS, Russia 0.02
Department of Pathology, MSKCC, United States of America (USA) 0.01
University Institute of Oncology of Asturias - Cajastur Social Programme (IUOPA), UniOvi, Spain 0.01
Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Spain 0.01
UK Markey Cancer Center, United States of America (USA) 0.01
Department of Radiation Sciences, UMU, Sweden 0.01
Marius Nasta Institute of Pneumology, Romania 0.01
First Faculty of Medicine, CU, Czech Republic 0.01
Department of Medical Biosciences, UMU, Sweden 0.01
Cancer Cluster Salzburg (CCS), Austria 0.01
Faculty of Health Sciences, PU, Czech Republic 0.01
Department of Thoracic Oncology, MOFFITT, United States of America (USA) 0.01
UPMC Hillman Cancer Center (UPCI), United States of America (USA) 0.01
Department of Cancer Epidemiology and Prevention, MCMCC, Poland 0.01
International Organization for Cancer Prevention and Research (IOCPR), Serbia 0.01
National Institute of Tuberculosis and Lung Diseases (NITLD), Poland 0.01
Department of Environmental Epidemiology, NIOM, Poland 0.01
Department of Clinical Science (K2), UIB, Norway 0.01
The Institute of Cancer Research (ICR), United Kingdom (UK) 0.01
University of Toronto (U of T), Canada 0.01
American Cancer Society (ACS), United States of America (USA) 0.01
Merck Research Laboratories (MRL) - Boston, United States of America (USA) 0.01
Centre for Heart Lung Innovation (HLI), Canada 0.01
Department of Biostatistics, MD Anderson Cancer Center, United States of America (USA) 0.01
Division of Clinical Epidemiology and Aging Research, DKFZ, Germany 0.01
Research Unit of Molecular Epidemiology (AME), HMGU, Germany 0.01
Hellenic Health Foundation (HHF), Greece 0.01
Public Health Sciences Division (PHS), FHCRC, United States of America (USA) 0.01
Department of Epidemiology and Biostatistics (EPBI), CWRU, United States of America (USA) 0.01
Ruth and Bruce Rappaport Faculty of Medicine, IIT, Israel 0.01
University Medical Center Göttingen (UMG), Germany 0.01
Dartmouth-Hitchcock Norris Cotton Cancer Center, United States of America (USA) 0.01
WSU Department of Pharmaceutical Sciences, United States of America (USA) 0.01
BC Cancer Agency (BCCA), PHSA, Canada 0.01
Department of Cancer Epidemiology, MOFFITT, United States of America (USA) 0.01
Department of Epidemiology, Dartmouth College, United States of America (USA) 0.01
IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Italy 0.01
IRCCS-UNIMI Department of Clinical Sciences and Community Health (DISCCO), Italy 0.01
College of Life Sciences, Sejong University, South Korea 0.01
Division of Oncology and Pathology, LU, Sweden 0.01
School of Public Health (SPH), ICL, United Kingdom (UK) 0.01
Quebec Heart and Lung Institute (IUCPQ), UL, Canada 0.01
Department of Molecular Medicine, UL, Canada 0.01
Cancer Registry and Histopathology Unit, Azienda Ospedaliera Civile M.P. Arezzo, Italy 0.01
Clalit National Israeli Cancer Control Center (NICCC), Israel 0.01
Department of Pathology and Medical Biology, RUG, Netherlands 0
Groningen Research Institute for Asthma and COPD (GRIAC), RUG, Netherlands 0
Department of Medicine, MGH, United States of America (USA) 0
Department of Epidemiology and Biostatistics, MSKCC, United States of America (USA) 0
Swedish Medical Center, United States of America (USA) 0
Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA) 0
School of Medicine (BUSM), University of Belgrade, Serbia 0
Clinical Centre of Serbia, Serbia 0
USC Department of Preventive Medicine, United States of America (USA) 0
USC Norris Comprehensive Cancer Center, United States of America (USA) 0
Translational Lung Research Center Heidelberg (TLRC), Germany 0
Thoraxklinik Universitätsklinikum Heidelberg, Uni Heidelberg, Germany 0
Dan L. Duncan Comprehensive Cancer Center, United States of America (USA) 0
Genetic Epidemiology Group, University of Leicester, United Kingdom (UK) 0
NIHR Leicester Respiratory Biomedical Research Unit (BRU), United Kingdom (UK) 0
Glenfield Hospital, United Kingdom (UK) 0
Gentofte University Hospital, Denmark 0
Herlev University Hospital, Denmark 0
The Copenhagen General Population Study, Denmark 0
Faculty of Health and Medical Sciences, UCPH, Denmark 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER